Bursin as an adjuvant is a potent enhancer of immune response in mice immunized with the JEV subunit vaccine

Veterinary Immunology and Immunopathology

Volumn 122, Issue 3-4, 2008, Pages 265-274

  Wang, Chen ^a,b   Wen, Wen yan ^c   Su, Chun xia ^d   Ge, Fei fei ^a   Dang, Zhan guo ^a   Duan, Xiang guo ^d   Cao, Rui bing ^a   Zhou, Bing ^a   Chen, Pu yan ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c NORTHWEST A F UNIVERSITY   (China)

^d NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant; Bursin; JEV; Peptide

Indexed keywords

ANTIGEN; CHOLINE; CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 4; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; SYNTHETIC PEPTIDE; VIRUS ANTIBODY;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELL COMPOSITION; EPIDEMIC ENCEPHALITIS; IMMOBILIZED CELL; IMMUNE RESPONSE; IMMUNITY; JAPANESE ENCEPHALITIS VIRUS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; SPLEEN LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; FEMALE; IMMUNOGLOBULIN G; JAPANESE ENCEPHALITIS VACCINES; LYMPHOCYTES; MICE; NEUTRALIZATION TESTS; OLIGOPEPTIDES; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; SPLEEN;

ESCHERICHIA COLI; JAPANESE ENCEPHALITIS VIRUS; MUS;

EID: 40949161007     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.11.010     Document Type: Article

References (49)

1. Abiko T., and Sekino H. Syntheses and effect of bursin and it analogs on the reduced B lymphocytes of uremic patients. Biotechnol. Ther. 5 (1994) 163-170
2. Aguilar J.C., and Rodriguez E.G. Vaccine adjuvants revisited. Vaccine 25 (2007) 3752-3762
3. Audhya T., King R., and Goldstein G. Bovine probursin tetradecapeptide contains amino acid sequence from somatostatin, tuftsin and bursin. Life Sci. 48 (1991) 773-780
4. Audhya T., Kroon D., Heavner G., Viamontes G., and Goldstein G. Tripeptide structure of bursin, a selective B-cell-differentiating hormone of the bursa of Fabricius. Science (New York, NY) 231 (1986) 997-999
5. Audhya T., Viamontes G., Babu U., and Goldstein G. Bursin localization in mammalian bone marrow and epithelial cells of intrahepatic bile ducts. Scand. J. Immunol. 31 (1990) 199-204
6. Baba T., and Kita M. Effect of extracts of the bursa of Fabricius on IgG antibody production in hormonally bursectomized chickens. Immunology 32 (1977) 271-274
7. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., and Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science (New York, NY) 298 (2002) 1025-1029
8. Brand A., Gilmour D.G., and Goldstein G. Lymphocyte-differentiating hormone of bursa of Fabricius. Science (New York, NY) 193 (1976) 319-321
9. Burke D.S., and Monath T.P. Flaviviridae. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. fourth ed. (2001), Lippincott-Williams and Wilkins, New York 1043-1125
10. Charoenvit Y., Goel N., Whelan M., Rosenthal K.S., and Zimmerman D.H. CEL-1000-a peptide with adjuvant activity for Th1 immune responses. Vaccine 22 (2004) 2368-2373
11. Chen Y., Maguire T., Hileman R.E., Fromm J.R., Esko J.D., Linhardt R.J., and Marks R.M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 8 (1997) 866-871
12. Fritz J.H., Brunner S., Birnstiel M.L., Buschle M., Gabain A., Mattner F., and Zauner W. The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens. Vaccine 22 (2004) 3274-3284
13. Fujisaki Y., Sugimori T., Morimoto T., and Miura Y. Development of an attenuated strain for Japanese encephalitis live virus vaccine for porcine use. Natl. Inst. Anim. Health Q. 15 (1975) 15-23
14. Gagnon L., DiMarco M., Kirby R., Zacharie B., and Penney C.L. d-LysAsnProTyr tetrapeptide: a novel B-cell stimulant and stabilized bursin mimetic. Vaccine 18 (2000) 1886-1892
15. Ge F.F., Qiu Y.F., Gao X.F., Yang Y.W., and Chen P.Y. Fusion expression of major antigenic segment of JEV E protein-hsp70 and the identification of domain acting as adjuvant in hsp70. Vet. Immunol. Immunopathol. 113 (2006) 288-296
16. Ge F.F., Qiu Y.F., Yang Y.W., and Chen P.Y. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus. Arch. Virol. 152 (2007) 125-135
17. Horton R.M., Hunt H.D., Ho S.N., Pullen J.K., and Pease L.R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77 (1989) 61-68
18. Hou H.Y., Liu J., Chen N.H., Peng J.P., and Jin Y.L. Influence of positive phage of phage-displayed bursin-mimic peptide on immunological effects of NDV live vaccine. Acta Agriculturae Universitatis Jiangxiensis 29 (2007) 608-611 (in Chinese, with English abstract)
19. Inoue Y.K. An attenuated Japanese encephalitis vaccine. Prog. Med. Virol. 19 (1975) 247-256
20. Jamgaonkar A.V., Yergolkar P.N., Geevarghese G., Joshi G.D., Joshi M.V., and Mishra A.C. Serological evidence for Japanese encephalitis virus and West Nile virus infections in water frequenting and terrestrial wild birds in Kolar District, Karnataka State, India. A retrospective study. Acta Virol. 47 (2003) 185-188
21. Kimura K.J., and Yasui K. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol. 141 (1988) 3606-3610
22. Konno J., Endo K., Agatsuma H., and Ishida N. Cyclic outbreaks of Japanese encephalitis among pigs and humans. Am. J. Epidemiol. 84 (1966) 292-300
23. Kumar D.A., Manikandan P., Sumitra M., Raju K.V., Gayathri C., Arutselvan N., and Puvanakrishnan R. A novel peptide derivative exhibits anti inflammatory and antioxidant activity in adjuvant induced arthritis in rats. Mol. Cell. Biochem. 229 (2002) 9-17
24. 2 in avian and murine B cell development. Cell. Immunol. 122 (1989) 319-328
25. Lee C.G., Choi S.Y., Park S.H., Park K.S., Ryu S.H., and Sung Y.C. The synthetic peptide Trp-Lys-Tyr-Met-Val-d-Met as a novel adjuvant for DNA vaccine. Vaccine 23 (2005) 4703-4710
26. Mall M.P., Kumar A., and Malik S.V. Sero-positivity of domestic animals against Japanese encephalitis in Barelly area. U.P. J. Commun. Dis. 27 (1995) 242-246
27. Marques A.F., da Silva M.B., Juliano M.A., Travassos L.R., and Taborda C.P. Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis. Antimicrob. Agents Chemother. 50 (2006) 2814-2819
28. Mason P.W., Pincus S., Fournier M.J., Mason T.L., Shope R.E., and Paoletti E. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180 (1991) 294-305
29. Monath T.P. Pathobiology of the flaviviruses. In: Schlesinger S., and Schlesinger M.J. (Eds). The Togaviridae and Flaviviridae (1986), Plenum Press, New York 375-440
30. Nidaira M., Taira K., Itokazu K., Kudaka J., Nakamura M., Ohno A., and Takasaki T. Survey of the antibody against Japanese encephalitis virus in Ryukyu Wild Boars (Sus scrofa riukiuanus) in Okinawa, Japan. Jpn. J. Infect. Dis. 60 (2007) 309-311
31. Oya A. The role of mammals as primary and supplementary hosts. Jpn. J. Med. Sci. Biol. 20 Suppl. (1967) 26-30
32. Pant G.R. A serological survey of pigs, horses, and ducks in Nepal for evidence of infection with Japanese encephalitis virus. Ann. N.Y. Acad. Sci. 1081 (2006) 124-129
33. Pant G.R., Lunt R.A., Rootes C.L., and Daniels P.W. Serological evidence for Japanese encephalitis and West Nile viruses in domestic animals of Nepal. Comp. Immunol. Microbiol. Infect. Dis. 29 (2006) 166-175
34. Petrovsky N., and Aguilar J.C. Vaccine adjuvants: current state and future trends. Immunol. Cell Biol. 82 (2004) 488-496
35. Pockley A.G. Heat shock proteins as regulators of the immune response. Lancet 362 (2003) 469-476
36. Qazi K.R., Wikman M., Vasconcelos N.M., Berzins K., Stahl S., and Fernandez C. Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene. Vaccine 23 (2005) 1114-1125
37. Rey F.A., Heinz F.X., Mandl C., Kunz C., and Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375 (1995) 291-298
38. Robert J. Evolution of heat shock protein and immunity. Dev. Comp. Immunol. 27 (2003) 449-464
39. Scherer W.F., Moyer J.T., Izumi T., Gresser I., and Mc C.J. Ecologic studies of Japanese encephalitis virus in Japan. VI: Swine infection. Am. J. Trop. Med. Hyg. 8 (1959) 698-706
40. Shope R.E. Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals. In: Schlesinger R.W. (Ed). The Togaviruses (1980), Academic Press, New York 47-82
41. Takeuchi H., Baba M., and Shigeta S. An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. J. Virol. Methods 33 (1991) 61-71
42. Trimble C., Lin C.T., Hung C.F., Pai S., Juang J., He L., Gillison M., Pardoll D., Wu L., and Wu T.C. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 21 (2003) 4036-4042
43. Van N.E., Zwick M.B., Menendez A., and Scott J.K. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide. Vaccine 24 (2006) 4188-4200
44. Vrati S., Agarwal V., Malik P., Wani S.A., and Saini M. Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth. J. Gen. Virol. 80 (1999) 1665-1671
45. Vythilingam I., Oda K., Mahadevan S., Abdullah G., Thim C.S., Hong C.C., Vijayamalar B., Sinniah M., and Igarashi A. Abundance, parity, and Japanese encephalitis virus infection of mosquitoes (Diptera: Culicidae) in Sepang District, Malaysia. J. Med. Entomol. 34 (1997) 257-262
46. Wang Y., Kelly C.G., Singh M., McGowan E.G., Carrara A.S., Bergmeier L.A., and Lehner T. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 169 (2002) 2422-2429
47. Yamanaka T., Tsujimura K., Kondo T., Yasuda W., Okada A., Noda K., Okumura T., and Matsumura T. Isolation and genetic analysis of Japanese encephalitis virus from a diseased horse in Japan. J. Vet. Med. Sci. 68 (2006) 293-295
48. Yang D.K., Kweon C.H., Kim B.H., Hwang I.J., Kang M.I., So B.J., and Cho K.O. The seroprevalence of Japanese encephalitis virus in goats raised in Korea. J. Vet. Sci. 8 (2007) 197-199
49. Zhao M.J., Chen N.H., Wang P., and Qu Y. Studies on phage-displayed bursin-mimic peptide. Chin. J. Prev. Vet. Med. 27 (2005) 277-282 (in Chinese, with English abstract)